Expression Systems is a number one provider of modern cell tradition media, baculovirus molecular reagents and cell strains utilized in superior biological-based therapeutics
BUFFALO GROVE, Ill. and DAVIS, Calif., Nov. 9, 2022 /PRNewswire/ — ANGUS Chemical Company (“ANGUS” or “Company”), a number one world producer and marketer of specialty substances for Life Sciences and Industrial markets, right now introduced it has acquired Expression Systems, LLC (“Expression Systems”), a number one world producer of cell tradition media and associated services. ANGUS is a portfolio firm of Ardian and Golden Gate Capital.
Founded in 1997, Expression Systems is devoted to supplying and servicing the baculovirus expression platform with modern cell tradition media formulations, in addition to cell strains, molecular instruments, reagents and contract providers. Expression Systems operates from a central headquarters in Davis, California, and is cGMP-compliant and ISO 13485 licensed for its manufacturing and analysis actions.
“The acquisition of Expression Systems is an important step in expanding ANGUS’ leadership position in Life Sciences beyond bio buffers into specialty cell culture media, a strategic adjacency with high customer overlap and complementary product and service offerings,” stated ANGUS President and Chief Executive Officer David Neuberger. “The combination of ANGUS and Expression Systems further strengthens our ability to deliver value through the consistent, high-quality ingredients and services essential to all phases of bioprocessing, from early-stage biologics development to full-scale commercial production.”
Expression Systems is a well-recognized impartial supplier of specialised cell tradition media and associated merchandise with a strong observe file of product high quality and innovation based mostly on proprietary expertise. The firm makes a speciality of baculovirus expression vector system (BEVS) and has deep experience throughout the method from gene optimization to protein purification. Expression Systems’ merchandise are utilized primarily by structural biology researchers and biologics producers to supply sure drug candidates, protein-based therapies, vaccines and gene therapies effectively and cost-effectively.
“For more than 20 years, our family and dedicated employees have built a strong reputation with its customers by leveraging our world-renowned technical expertise in media manufacturing and the baculovirus expression platform,” stated Expression Systems President and Chief Executive Officer David Hedin. “When we looked ahead to the future for our company, it was clear that ANGUS was in the best position to provide new opportunities to our current and new customers, as well as our employees. ANGUS will enhance our position as a dedicated, world-leading vendor focused on servicing the biologics industry segments employing the baculovirus expression platform.”
Achelous Partners, LLC served as unique M&A advisor to Expression Systems, LLC on this transaction.
ABOUT ANGUS
ANGUS is a number one world producer and marketer of specialty substances and consumables for biotechnology, pharmaceutical, client and industrial functions. The Company innovates by its distinctive nitroalkane chemistries, together with its flagship AMP™ (aminomethyl propanol) multifunctional components and TRIS AMINO™ (tromethamine) buffers, that are produced at totally built-in, ISO 9001-certified manufacturing services in the United States and Germany. ANGUS serves its world prospects by six regional Customer Application Centers positioned in Chicago, Illinois; Paris, France; São Paulo, Brazil; Singapore; Shanghai, China; and Mumbai, India. The Company is privately owned by Ardian and Golden Gate Capital, and is headquartered in Buffalo Grove, Illinois. For extra info, go to angus.com.
Follow ANGUS on Facebook, Twitter, and LinkedIn.
FOR ADDITIONAL INFORMATION
ANGUS Media Relations
Scott C. Johnson
+1 847-808-3769
[email protected]
Logo – https://mma.prnewswire.com/media/460234/ANGUS_Chemical_Company_Logo.jpg
View unique content material:https://www.prnewswire.co.uk/news-releases/angus-acquires-expression-systems-llc-301673591.html
